Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.35 |
| ▸ | TRPC3 | Q13507 | 1/20 | 0.35 |
| ▸ | TRPC6 | Q9Y210 | 1/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 3/20 | 0.34 |
| ▸ | FASN | P49327 | 1/20 | 0.34 |
| ▸ | EGLN2 | Q96KS0 | 2/20 | 0.34 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7910632 | 1.00 | CYP2C9 (0.49) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL5886341 | 1.00 | CYP2C9 (0.49) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL7908258 | 0.94 | CYP2C9 (0.42) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL7507632 | 0.94 | CYP2C9 (0.42) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL14300473 | 0.94 | CYP2C9 (0.49) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL13325809 | 0.93 | CYP2C9 (0.42) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL7514450 | 0.93 | CYP2C9 (0.42) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL7907223 | 0.93 | CYP2C9 (0.42) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL14526025 | 0.92 | CYP2C9 (0.43) | CYP2C9ALDH1A1MAPTLMNAMEN1 | |
| SCHEMBL7516179 | 0.92 | CYP2C9 (0.38) | CYP2C9ALDH1A1MAPTLMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10011773-B2 | Liquid crystal display device | DIC CORPORATION (JP) | 2018-07-03 | — | — | US | disclosed |
| US-20180171229-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2018-06-21 | — | — | US | disclosed |
| US-20180171234-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | DIC CORPORATION (JP) | 2018-06-21 | — | — | US | disclosed |
| US-20180134961-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME | DIC CORPORATION (JP) | 2018-05-17 | — | — | US | disclosed |
| US-9809752-B2 | Liquid crystal display device | DIC CORPORATION (JP) | 2017-11-07 | — | — | US | disclosed |
| US-9507185-B2 | Switch element comprising a liquid crystalline medium | MERCK PATENT GMBH (DE) | 2016-11-29 | — | — | US | disclosed |
| US-9410086-B2 | Liquid crystal-polymer composite material | DIC CORPORATION (JP) | 2016-08-09 | — | — | US | disclosed |
| US-9410086-B2 | Liquid crystal-polymer composite material | DIC CORPORATION (JP) | 2016-08-09 | — | — | US | disclosed |
| US-20160215217-A1 | LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2016-07-28 | — | — | US | disclosed |
| US-20160215217-A1 | LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2016-07-28 | — | — | US | disclosed |
| US-8252202-B2 | Nematic liquid crystal composition and bistable nematic liquid crystal display | DIC CORPORATION (JP) | 2012-08-28 | — | — | US | disclosed |
| US-20110211148-A1 | NEMATIC LIQUID CRYSTAL COMPOSITION AND BISTABLE NEMATIC LIQUID CRYSTAL DISPLAY | DIC CORPORATION (JP) | 2011-09-01 | — | — | US | disclosed |
| WO-2010145211-A1 | LIQUID FLUORESCENT COMPOSITION AND LIGHT EMITTING DEVICE | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (CN) | 2010-12-23 | — | — | WO | disclosed |
| US-20100201930-A1 | NEMATIC LIQUID CRYSTAL COMPOSITION AND BISTABLE NEMATIC LIQUD CRYSTAL DISPLAY | DIC CORPORATION (JP) | 2010-08-12 | — | — | US | disclosed |
| US-7622056-B2 | High dielectric anisotropy liquid crystal compound and composition containing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2009-11-24 | — | — | US | disclosed |
| US-20080135803-A1 | High dielectric anisotropy liquid crystal compound and composition containing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE DAILY POLYMER CORPORATION | 2008-06-12 | — | — | US | disclosed |
| US-7294368-B2 | Liquid crystal composition for use in bistable liquid crystal devices | MERCK PATENT GMBH (DE) | 2007-11-13 | — | — | US | disclosed |
| US-7258903-B2 | Fast switching liquid crystal compositions for use in bistable liquid crystal devices | MERCK PATENT GMBH (DE) | 2007-08-21 | — | — | US | disclosed |
| US-7198827-B1 | Nematic liquid crystal composition and liquid crystal display device using the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-04-03 | — | — | US | disclosed |
| US-7198827-B1 | Nematic liquid crystal composition and liquid crystal display device using the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2007-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080135803-A1 | High dielectric anisotropy liquid crystal compound and composition containing the same | KIF23, PIEZO1, KIFC1 | CYP2C9 1643/4885ALDH1A1 3546/4885MAPT 72/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.